Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database JJ Leow, SL Chang, CP Meyer, Y Wang, J Hanske, JD Sammon, AP Cole, ... European urology 70 (5), 837-845, 2016 | 250 | 2016 |
Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers EB Cone, M Marchese, M Paciotti, DD Nguyen, J Nabi, AP Cole, G Molina, ... JAMA network open 3 (12), e2030072-e2030072, 2020 | 153 | 2020 |
Where is the value in ambulatory versus inpatient surgery? DF Friedlander, MJ Krimphove, AP Cole, M Marchese, SR Lipsitz, ... Annals of surgery 273 (5), 909-916, 2021 | 101 | 2021 |
Association of care at minority-serving vs non–minority-serving hospitals with use of palliative care among racial/ethnic minorities with metastatic cancer in the United States AP Cole, DD Nguyen, A Meirkhanov, M Golshan, N Melnitchouk, ... JAMA network open 2 (2), e187633-e187633, 2019 | 90 | 2019 |
Cognitive impairment in men with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis M Sun, AP Cole, N Hanna, LA Mucci, DL Berry, S Basaria, DK Ahern, ... The Journal of urology 199 (6), 1417-1425, 2018 | 90 | 2018 |
Variations in the costs of radical cystectomy for bladder cancer in the USA JJ Leow, AP Cole, T Seisen, J Bellmunt, M Mossanen, M Menon, ... European urology 73 (3), 374-382, 2018 | 87 | 2018 |
Efficacy of high-intensity local treatment for metastatic urothelial carcinoma of the bladder: a propensity score–weighted analysis from the National Cancer Data Base T Seisen, M Sun, JJ Leow, MA Preston, AP Cole, F Gelpi-Hammerschmidt, ... Journal of Clinical Oncology 34 (29), 3529-3536, 2016 | 87 | 2016 |
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer MJ Krimphove, AP Cole, SA Fletcher, SS Harmouch, S Berg, SR Lipsitz, ... Prostate cancer and prostatic diseases 22 (1), 125-136, 2019 | 79 | 2019 |
Secondary data analysis: techniques for comparing interventions and their limitations AP Cole, QD Trinh Current opinion in urology 27 (4), 354-359, 2017 | 76 | 2017 |
Secondary data sources for health services research in urologic oncology AP Cole, DF Friedlander, QD Trinh Urologic Oncology: Seminars and Original Investigations 36 (4), 165-173, 2018 | 74 | 2018 |
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic … S Berg, D D’Andrea, MW Vetterlein, AP Cole, SA Fletcher, MJ Krimphove, ... Cancer 125 (9), 1449-1458, 2019 | 66 | 2019 |
Establishment of a new prostate cancer multidisciplinary clinic: format and initial experience D Sundi, JE Cohen, AP Cole, BP Neuman, J Cooper, FA Faisal, AE Ross, ... The Prostate 75 (2), 191-199, 2015 | 61 | 2015 |
Contemporary national trends in prostate cancer risk profile at diagnosis SA Fletcher, N Von Landenberg, AP Cole, P Gild, TK Choueiri, SR Lipsitz, ... Prostate Cancer and Prostatic Diseases 23 (1), 81-87, 2020 | 58 | 2020 |
Geographic distribution of racial differences in prostate cancer mortality SA Fletcher, M Marchese, AP Cole, BA Mahal, DF Friedlander, ... JAMA network open 3 (3), e201839-e201839, 2020 | 51 | 2020 |
Comparative effectiveness of radical prostatectomy versus external beam radiation therapy plus brachytherapy in patients with high-risk localized prostate cancer S Berg, AP Cole, MJ Krimphove, J Nabi, M Marchese, SR Lipsitz, ... European Urology 75 (4), 552-555, 2019 | 50 | 2019 |
Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men AP Cole, J Hanske, W Jiang, NK Kwon, SR Lipsitz, M Kathrins, PA Learn, ... BJU international 121 (5), 811-818, 2018 | 50 | 2018 |
Surgeon and hospital level variation in the costs of robot-assisted radical prostatectomy AP Cole, JJ Leow, SL Chang, BI Chung, CP Meyer, AS Kibel, M Menon, ... The Journal of urology 196 (4), 1090-1095, 2016 | 49 | 2016 |
Quality of care in the treatment of localized intermediate and high risk prostate cancer at minority serving hospitals MJ Krimphove, SA Fletcher, AP Cole, S Berg, M Sun, SR Lipsitz, ... The Journal of urology 201 (4), 735-741, 2019 | 47 | 2019 |
Access denied: the relationship between patient insurance status and access to high‐volume hospitals J Nabi, KH Tully, AP Cole, M Marchese, EB Cone, N Melnitchouk, ... Cancer 127 (4), 577-585, 2021 | 44 | 2021 |
Liver disease in men undergoing androgen deprivation therapy for prostate cancer P Gild, AP Cole, A Krasnova, BA Dickerman, N von Landenberg, M Sun, ... The Journal of urology 200 (3), 573-581, 2018 | 43 | 2018 |